Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
HRMY on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
57.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
47.3M
Holdings value
$1.3B
% of all portfolios
0.009%
Grand Portfolio weight change
0%
Number of holders
289
Number of buys
154
Number of sells
-114
Average Value change %
-0.03%
Average buys %
+0.001%
Average sells %
-0.03%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Marshman Fund Trust II 10.6% $178M 6.05M Marshman Fund Trust II 31 Dec 2024
BlackRock, Inc. 10.1% -17.5% $170M -$35.3M 5.77M -17.2% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 8.3% $139M 4.73M The Vanguard Group 31 Dec 2024
FMR LLC 6.7% $106M 3.85M FMR LLC 30 Sep 2025

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 47.3M $1.3B -$115M $27.56 289
2025 Q2 51.3M $1.62B +$22.3M $31.60 276
2025 Q1 50.2M $1.66B -$101M $33.19 267
2024 Q4 52.7M $1.81B +$62.3M $34.41 244
2024 Q3 50.1M $2.01B +$11.1M $40.00 231
2024 Q2 50.2M $1.51B +$34.7M $30.17 218
2024 Q1 49M $1.64B +$41.1M $33.58 206
2023 Q4 47.8M $1.54B -$51.1M $32.30 219
2023 Q3 49.5M $1.62B -$85.5M $32.77 203
2023 Q2 52M $1.83B +$28.8M $35.19 207
2023 Q1 51.3M $1.67B -$29.6M $32.65 213
2022 Q4 51M $2.81B +$34.9M $55.10 238
2022 Q3 50.5M $2.24B +$91.7M $44.29 195
2022 Q2 47.9M $2.34B +$99.7M $48.77 173
2022 Q1 45.9M $2.24B +$80M $48.65 168
2021 Q4 44.5M $1.9B +$107M $42.64 138
2021 Q3 30.9M $1.19B +$116M $38.33 99
2021 Q2 28M $790M -$7.61M $28.23 79
2021 Q1 27.5M $908M -$18.5M $33.04 55
2020 Q4 28M $998M -$18.7M $36.15 59
2020 Q3 28.5M $941M +$941M $33.90 44